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Introduction
Insulin resistance is a hall mark of metabolic disorders.
Studies have demonstrated that inflammatory regulator
interleukin-6 (IL-6) plays an important role in disruption
of IR/Akt/eNOS signaling pathway resulting vascular
insulin resistance. Accumulating evidences suggests a
significant role of epigenetic mechanisms such as DNA
methylation in progression of metabolic disorders. Hence
the present study aimed to understand the role of epige-
netic mechanisms involved during IL-6 induced vascular
insulin resistance and its consequences in cardiovascular
diseases.
Materials and methods
Human umbilical vein endothelial cells (HUVEC) and
Human dermal microvascular endothelial cells (HDMEC)
were used for this study. Endothelial cells were treated in
presence or absence IL-6 (20ng/ml) for 36 hours and fol-
lowed by insulin (100nM) stimulation for 15 minutes.
Levels of phosphorylated- and total Akt served as readout
for insulin resistance. To investigate changes in DNA
methylation, cells were treated with or without neutro-
phil conditioned medium (NCM) as a physiological
source of inflammation or IL-6 for 36 hours. Genomic
DNA was processed for HPLC analysis for methyl cyto-
sine content and cell lysates were analyzed for DNMT1
(DNA (cytosine-5)-methyltransferase 1) and DNMT3A
(DNA (cytosine-5)-methyltransferase 3A) levels using
immunoblotting.
Results
Endothelial cells stimulated with insulin exhibited an
increase in phosphorylation of Akt ser 473 in serum free
conditions but such insulin response was not observed
in cells treated with IL-6, suggesting chronic exposure
of endothelial cells to IL-6 leads to insulin resistance.
HPLC analysis for global DNA methylation resulted in
decreased levels of methyl cytosine in cells treated with
pro-inflammatory molecules (both by NCM and IL6) as
compared to 3.2% in untreated control to 2% in treated.
Kinetic studies depicted a transient increase DNA
methylation at 24 hours which was followed by steep
decrease at 36 hours. Subsequently, analysis in cells treated
with IL-6 showed a significant decrease in DNMT1 levels
but not in DNMT3A. Other pro-inflammatory marker
such as TNF-a did not exhibit such changes. Interestingly
we also observed Akt phsophorylation refelcetd DNMT1
changes suggesting plausible role of PI3K/Akt signaling
axis in regulation of DNMT1 expression.
Conclusion
Taken together our study suggests that IL-6 induces
vascular insulin resistance and involvement of epigenetic
changes.
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